Identification of 16S rRNA mutations in Mycoplasma genitalium potentially associated with tetracycline resistance in vivo but not selected in vitro in M. genitalium and Chlamydia trachomatis. (4th February 2021)

• Record Type: Journal Article
• Authors: Le Roy, Chloé; Touati, Arabella; Balcon, Carla; Garraud, Justine; Molina, Jean-Michel; Berçot, Béatrice; de Barbeyrac, Bertille; Pereyre, Sabine; Peuchant, Olivia; Bébéar, Cécile
• Is Part Of: Journal of antimicrobial chemotherapy. Volume 76:Number 5(2021)
• Page Start: 1150
• Page End: 1154
• Publication Date: 2021-02-04
• Subjects: Anti-infective agents -- Periodicals; Chemotherapy -- Periodicals; 615.58
• DOI: 10.1093/jac/dkab016
• Languages: English
• ISSNs: 0305-7453

Abstract

Abstract: Objectives: Tetracyclines are widely used for the treatment of bacterial sexually transmitted infections (STIs) and recently have been used successfully for post-exposure prophylaxis of STIs in MSM. We investigated the in vitro and in vivo development of tetracycline resistance in Chlamydia trachomatis and Mycoplasma genitalium and evaluated 16S rRNA mutations associated with acquired resistance in other bacteria. Methods: In vitro selection of resistant mutants of reference strains of C. trachomatis and M. genitalium was undertaken by serial passage in medium containing subinhibitory concentrations of tetracycline or doxycycline, respectively. The 16S rRNA gene of the two microorganisms was amplified and sequenced at different passages, as were those of 43 C. trachomatis - and 106 M. genitalium -positive specimens collected in France from 2013 to 2019. Results: No tetracycline- or doxycycline-resistant strains of C. trachomatis and M. genitalium, respectively, were obtained after 30 serial passages. The tetracycline and doxycycline MICs were unchanged and analysis of the 16S rRNA gene, the molecular target of tetracyclines, of C. trachomatis and M. genitalium revealed no mutation. No mutation in the 16S rRNA gene was detected in C. trachomatis -positive specimens. However, six M. genitalium -positive specimens harboured a mutation potentially associated with tetracycline resistance without known prior tetracycline treatment for patients. Conclusions: Tetracyclines did not select in vitro -resistant mutants of C. trachomatis or M. genitalium . However, 16S rRNA mutations either responsible for or associated with tetracycline resistance in other bacteria, including mycoplasma species, were identified in several M. genitalium -positive specimens.